Comentarios dos nossos clientes
Search:
Perform search
Lista de Categorias

Genéricos Cyclophosphamide - Cytoxan

Novidades
Busca por letra:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Cytoxan
Genérico Cytoxan é usado para tratar certos tipos dos seguintes cancros: linfoma, mieloma múltiplo, leucemia, micose fungóide, neuroblastoma, cancro nos ovários, olhos e mama. É normalmente usado em combinação com outros medicamentos. Pode também ser usado para tratar alguns tipos de problemas nos rins (síndrome nefrótica) em crianças.
€0.66
Bookmarks sociais
Choose your language:



Garantiade reembolso
Comprasegura

Nossa página de faturamento é certificada por:

Secure shopping certificates

Special Offer!

  • Cyclophosphamide drug makes the bone marrow more tumor-friendly - News-Medical.net

    Cyclophosphamide drug makes the bone marrow more tumor-friendlyNews-Medical.

  • Docs Need Primer on Long-Term Effects of Chemotherapy - Family Practice News Digital Network

    Family Practice News Digital NetworkDocs Need Primer on Long-Term Effects of ChemotherapyFamily Practice News Digital NetworkOnly 6% of primary care physicians were able to identify the main long-term effects (LEs) of doxorubicin (Adriamycin), paclitaxel (Taxol), oxaliplatin (Eloxatin), and cyclophosphamide (Cytoxan), compared with 65% of oncologists surveyed.

  • ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule ... - MarketWatch (press release)

    ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule .

  • Clinical Conundrums - Clinical Oncology News

    Clinical Oncology NewsClinical ConundrumsClinical Oncology NewsTrue or False: In the SWOG S0016/CALGB 50102 trial for patients with previously untreated FL, inferior outcomes were observed with maintenance rituximab versus tositumomab/ 131 I-tositumomab (CHOP-RIT; GlaxoSmithKline) following cyclophosphamide, .

  • Diffuse Large B-Cell Lymphoma: Current Treatment Approaches - Cancer Network

    Diffuse Large B-Cell Lymphoma: Current Treatment ApproachesCancer NetworkWhile a series of trials support R-CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone, plus rituximab)-21 as the standard of care for all patients, DLBCL has substantial biological and clinical heterogeneity, leading to marked differences .

    Copyright © 2005-2010 Canadian Pharmacy Online Canada Pharmacy, Canadian Pharmacy.